{"id":47769,"date":"2025-11-07T12:00:00","date_gmt":"2025-11-07T11:00:00","guid":{"rendered":"https:\/\/inmuno.es\/index.php\/2025\/11\/07\/dual-targeted-therapy-with-baricitinib-and-anifrolumab-in-infantile-spondyloenchondrodysplasia-with-immune-dysregulation\/"},"modified":"2025-11-07T12:00:00","modified_gmt":"2025-11-07T11:00:00","slug":"dual-targeted-therapy-with-baricitinib-and-anifrolumab-in-infantile-spondyloenchondrodysplasia-with-immune-dysregulation","status":"publish","type":"post","link":"https:\/\/inmuno.es\/index.php\/2025\/11\/07\/dual-targeted-therapy-with-baricitinib-and-anifrolumab-in-infantile-spondyloenchondrodysplasia-with-immune-dysregulation\/","title":{"rendered":"Dual Targeted Therapy with Baricitinib and Anifrolumab in Infantile Spondyloenchondrodysplasia with Immune Dysregulation"},"content":{"rendered":"<div>\n<p><b>J Clin Immunol<\/b>. 2025 Nov 8;45(1):155. doi: 10.1007\/s10875-025-01954-3.<\/p>\n<p><b>NO ABSTRACT<\/b><\/p>\n<p>PMID:<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41203937\/?utm_source=SimplePie&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=8102137&amp;ff=20251108005341&amp;v=2.18.0.post22+67771e2\">41203937<\/a> | DOI:<a href=\"https:\/\/doi.org\/10.1007\/s10875-025-01954-3\">10.1007\/s10875-025-01954-3<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>J Clin Immunol. 2025 Nov 8;45(1):155. doi: 10.1007\/s10875-025-01954-3. NO ABSTRACT PMID:41203937 | DOI:10.1007\/s10875-025-01954-3<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,42],"tags":[],"class_list":["post-47769","post","type-post","status-publish","format-standard","hentry","category-journal-of-clinical-immunology","category-publicaciones"],"_links":{"self":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts\/47769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/comments?post=47769"}],"version-history":[{"count":0,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts\/47769\/revisions"}],"wp:attachment":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/media?parent=47769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/categories?post=47769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/tags?post=47769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}